Tomohiro Uto
Iwata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II study.
Journal: Journal for immunotherapy of cancer
Published: July 10, 2023
Predictors of poor clinical outcomes including in-hospital death and low ability to perform activities of daily living at discharge in hospitalized patients with chronic obstructive pulmonary disease exacerbation.
Journal: Therapeutic advances in respiratory disease
Published: May 23, 2023
Tracheobronchitis and laryngitis associated with Crohn's disease.
Journal: Respiratory medicine case reports
Published: April 16, 2023
Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy.
Journal: Cancer immunology, immunotherapy : CII
Published: November 05, 2022
A case of severe thrombocytopenia after the first exposure to rifampicin.
Journal: Respiratory medicine case reports
Published: October 30, 2022
BNT162b2 coronavirus disease-2019 vaccination accelerated rheumatoid arthritis disease activity in chronic eosinophilic pneumonia: A case report.
Journal: Medicine
Published: October 01, 2022
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer.
Journal: Journal of cancer research and clinical oncology
Published: April 22, 2022
Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.
Journal: Therapeutic advances in chronic disease
Published: January 25, 2022
Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies.
Journal: Respiratory medicine case reports
Published: October 05, 2021
Multicentric Castleman disease with infiltration of eosinophils to the lung.
Journal: Respiratory medicine case reports
Published: March 27, 2021
Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: March 10, 2021
Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung Cancer.
Journal: JAMA network open
Published: September 21, 2020
Last Updated: 09/26/2026